Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
about
A peptide filtering relation quantifies MHC class I peptide optimizationImmunoinformatics comes of ageT cell responses to human endogenous retroviruses in HIV-1 infectionHuman T cell responses to Japanese encephalitis virus in health and diseaseA frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusRecognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytesIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensCytotoxic T cell immunity against telomerase reverse transcriptase in humansIdentification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the ImmunoneA geometric and algebraic view of MHC-peptide complexes and their binding propertiesPrediction of MHC class I binding peptides, using SVMHCMULTIPRED: a computational system for prediction of promiscuous HLA binding peptides.PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse.Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.Prediction of MHC class II binding peptides based on an iterative learning model.Bioinformatics for cancer immunology and immunotherapyA guide to bioinformatics for immunologistsLassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.Reliable prediction of T-cell epitopes using neural networks with novel sequence representationsRapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 GenomeThe impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic familyCross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive IndividualsRecent advances in T-cell engineering for use in immunotherapyTumor neoantigens: building a framework for personalized cancer immunotherapyHLA-F complex without peptide binds to MHC class I protein in the open conformer form.NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequenceTrypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccineiSPOT: a web tool for the analysis and recognition of protein domain specificity.ImmunoNodes - graphical development of complex immunoinformatics workflowsMHC class II epitope predictive algorithms.The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine DesignIdentification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE.The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsProtection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) modelsRanking of binding and nonbinding peptides to MHC class I molecules using inverse folding approach: implications for vaccine design.
P2860
Q21092515-CFF6D8D3-9EBC-4C01-A39D-AA0DB3A88EE1Q21145682-5AB2815C-C4E9-4FCF-A239-7948025EB5CDQ21559508-2F0A1B46-5DC4-4CD2-8908-3B146DCAA020Q24289630-6358B409-A83A-41EA-B56A-D4728FDFD683Q24536117-E19F5861-0F28-41FE-A46E-FE84197D86DDQ24645078-5D271912-BC8D-40A0-BCE4-C9AAD439C4CDQ24672952-7C1580A4-E76B-46E1-9A09-087F9BBC358EQ24673417-C325BC92-3EB1-432D-8682-95BCB1266E42Q24676613-528453D1-C7A5-4064-910B-8B7A3A35D8D7Q24679680-0EF7B31A-8E87-4A07-8CD9-1A5D7E65CA51Q24798732-1A82D5FA-3696-4B2D-8C01-FA373A52B67CQ24801457-3D31CA4A-6E15-4AA9-9E0F-B14EFED8F98FQ24806545-C761BCE6-D8C9-46F2-8DC1-ABC21E6689AEQ24813031-8EAC56A3-2F3D-49EC-877A-85F9068FB6A0Q24813312-178F6534-7AE6-4A23-98BD-BA1ED5CBA894Q24815448-9A41FD8C-C64F-453E-98B5-8AA3D0A86122Q25257552-4F5A406E-C003-4736-953A-45E9B3FEB153Q26864876-67ABBC2A-FD49-41D4-8488-7F48081F35B9Q27024134-4F340B0C-EAA7-4E48-8082-286ABF32D0F6Q27472584-A9FAFF8A-C9FA-4BEF-99F6-BF6E57D12C42Q27485882-9C026C23-8BC7-4F57-B2DE-2402505DE855Q27487800-38E00531-A9A9-461A-85F2-9A2391918462Q27664962-DB9617FF-8473-4A33-BFA3-73EC6DA5D119Q27673689-80466243-647C-4373-B20B-ECDFB87AA7F4Q28080312-75153422-ED4B-4215-960C-84C3C08F917BQ28082704-DACC8D5A-39DB-4F86-98F0-58CD85DFDFC0Q28282824-F07BC25D-1237-49B7-9CA8-AA8475F6384CQ28469279-9D585B6E-DE31-4F4F-85DF-187B7B06130DQ28483146-EF4AD1D1-80B0-4148-8CFE-B107D0280E38Q30157638-61AD0C04-1FB0-4E7F-8696-F4EA8933F1F2Q30250980-0EFDF084-F092-4062-ABB4-AE9E9098BE0FQ30388353-6BAF1124-3B80-4683-AFAC-A24AA53E1BE8Q30400430-8E1C3016-5A3A-4B49-98BE-60A34C0FF1D7Q30418879-4985926C-0902-49F3-A8C5-C1B510614147Q30423203-D25E36DB-20E4-46CE-BAE4-C9B68E393C59Q30448796-10737549-5B73-4119-9C3C-87B6C30F1745Q30449492-76A8D95B-5C61-4B03-8EE1-B052AFCED23FQ30452642-69213FDE-80A1-44C6-B01A-B119292A36FAQ30477638-22FEE21C-0153-4EB5-9844-ACB73C2D8402Q30858758-8F5032F2-627B-439B-B036-1DBE70C0AC89
P2860
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Scheme for ranking potential H ...... ndividual peptide side-chains.
@ast
Scheme for ranking potential H ...... ndividual peptide side-chains.
@en
Scheme for ranking potential H ...... ndividual peptide side-chains.
@nl
type
label
Scheme for ranking potential H ...... ndividual peptide side-chains.
@ast
Scheme for ranking potential H ...... ndividual peptide side-chains.
@en
Scheme for ranking potential H ...... ndividual peptide side-chains.
@nl
prefLabel
Scheme for ranking potential H ...... ndividual peptide side-chains.
@ast
Scheme for ranking potential H ...... ndividual peptide side-chains.
@en
Scheme for ranking potential H ...... ndividual peptide side-chains.
@nl
P2093
P1476
Scheme for ranking potential H ...... individual peptide side-chains
@en
P2093
Bednarek MA
Coligan JE
P304
P407
P577
1994-01-01T00:00:00Z